[ad_1]
Moder or Corona 19 vaccine that the government decided to introduce. AFP = Yonhap News
The government signed a contract to buy a new vaccine against coronavirus infection (Corona 19) within this year with the American pharmaceutical company Modena, and announced that it will bring 20 million vaccines starting in the second quarter of next year (April to June ).
Blue House spokesman Kang Min-seok said in a briefing on the 29th: “The CEO of Stenfan Bansel Modena agreed to supply 40 million doses of 20 million people to Korea.” This is double the number of 10 million people that the current government has offered to insure through negotiations with Modena.
It was also decided to speed up the vaccine supply period. Modena originally decided to supply the supply from the third quarter of next year (July-September), but decided to start from the second quarter. Spokesman Kang explained, “We have decided to make additional efforts to speed up the supply period” and “we plan to sign a vaccine supply contract during this year.”
As a result, the amount the government claimed to have obtained increased by 10 million from 46 million to 56 million. If the vaccine arrives as planned, the population’s immunity is expected to form by the third quarter of next year, as the goal of the quarantine authorities.
Jung Eun-kyung, head of the Central Defense Countermeasures Headquarters, said at a regular briefing in Bangdaebon on the 28th: ”We will start vaccination from February to March and our goal is to build herd immunity by the third quarter.”
For population immunity, 60-70% of the total population must form antibodies. If the contract with Modena is completed within the year announced by the government, the number of insured vaccines will be 56 million people, surpassing the total population of Korea (518.3 million).
Astarazeneca’Corona 19 ‘vaccine that the government decided to introduce. Yunhap news
The government signed a contract with Janssen (for 6 million people) and Pfizer (for 10 million people) on the 23rd, and signed a supply contract for 10 million people with AstraZeneca on the 27th of last month. On October 9, an advance of 85 billion won was paid for the 10 million people insured through the Cobax Facility (a joint purchasing method through WHO).
Among the amounts that the government has secured, the vaccines scheduled to be introduced in the first half of next year are AstraZeneca (February-March), Janssen (April-June), Modena (April-June) and approximately 3750 of 1.5 millions of people between Kovacs facilities. It’s only for ten thousand. However, the supply schedule for 1.5 million Cobax facilities is still in the implementation stage by the government, and a specific supply schedule is expected to be released in January next year, and the timing of the completion of the introduction of the remaining vaccines is only in the first half of the year. Pfizer vaccines will begin entering the third quarter as soon as possible, but all promised quantities are expected to arrive from November through December.
Consequently, it is noted that even if the vaccine starts to be imported in the second quarter of next year, a specific vaccination plan should be prepared as soon as possible. Professor Kim Woo-joo, professor of infectious medicine at Korea University Hospital, said: “Think positively, even if all volumes go to the second quarter of next year, we should focus on vaccines from July to September of the next year to form a herd immunity in October. ” “Two weeks before winter” It is necessary to develop immunity so that it does not overlap with the influenza (flu) epidemic “.
Reporter Lee Tae-yoon [email protected]
[ad_2]
